GLOW Peptide Blend Explained featuring BPC-157, TB-500, and GHK-Cu in Peptide Bros neon style

GLOW Peptide Blend Explained: BPC-157, TB-500, GHK-Cu

What Is the GLOW Peptide Blend?

GLOW peptide blend is the name the peptide research community has given to a three-peptide combination: BPC-157, TB-500, and GHK-Cu. Rather than researchers ordering three separate vials, suppliers pre-combine them into a single lyophilized (freeze-dried) vial. Most commonly in a 5:1:1 ratio, meaning for every 50 mg of GHK-Cu, the blend contains 10 mg of BPC-157 and 10 mg of TB-500.

The name comes from the visible research interest in GHK-Cu’s role in skin and connective tissue remodeling, but the blend’s research scope extends well beyond skin. Spanning vascular, muscular, and connective-tissue research models.

The Three Peptides, Individually

Research overview of the GLOW peptide blend with BPC-157, TB-500, and GHK-Cu vials and laboratory documentation
BPC-157, TB-500, and GHK-Cu studied in tissue-repair research models | For Research Use Only

BPC-157 (Body Protection Compound-157) is a synthetic peptide that researchers sequenced from a partial protein they identified in human gastric juice. Studies have examined its role in angiogenesis and fibroblast migration in tendon models (Chang et al., J Appl Physiol), nitric-oxide signaling, and broader musculoskeletal healing outcomes across the preclinical literature (2025 systematic review, 36 studies).

TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein. Researchers study its role in actin regulation. The mechanism cells use to migrate, and have documented accelerated re-epithelialization and angiogenesis in cutaneous wound models (Malinda et al.), which explains why it appears frequently in systemic tissue-repair research alongside BPC-157.

GHK-Cu (Glycyl-L-Histidyl-L-Lysine, a copper-binding tripeptide) occurs naturally in human plasma and declines with age. It has one of the deepest research literatures of the three: foundational work by Pickart and Margolina documents its effects on collagen, elastin, and glycosaminoglycan synthesis, along with broad gene-expression modulation.

Why These Three Peptides Are Combined

Each peptide’s research profile targets a different piece of the tissue-repair pathway:

PeptidePrimary research focus
BPC-157Angiogenesis, gut/tendon models, inflammation signaling
TB-500Cell migration, systemic tissue models, actin regulation
GHK-CuCollagen/elastin synthesis, gene expression, copper-dependent enzyme activity

Because BPC-157 and TB-500 both intersect with angiogenesis pathways, and GHK-Cu contributes on the structural/collagen side, researchers studying combined tissue-repair models often look at all three together rather than in isolation. No published human trial has evaluated the three-peptide combination as a single formulation. Researchers draw the rationale for combining them from the individual-compound literature, not from combined-blend trials.

Glow peptide Composition and Concentration Reference explained

A standard pre-blended GLOW vial (70 mg total) breaks down as:

  • 50 mg GHK-Cu
  • 10 mg BPC-157
  • 10 mg TB-500

Reconstituting with 3.0 mL of bacteriostatic water yields an approximate total concentration of 23.3 mg/mL. Researchers working with lyophilized peptide blends generally reconstitute with bacteriostatic (not sterile) water when they need to store the solution for any length of time, and they keep the reconstituted vial refrigerated, out of light, and within the stability window the Certificate of Analysis (CoA) documents for that batch.

If you’d rather control the ratio yourself instead of using a fixed pre-blend, Peptide Bros offers a GLOW Bundle – BPC-157, TB-500, and GHK-Cu in three separate vials.

BPC-157 + TB-500 + GHK-Cu GLOW Bundle Peptide Bros
BPC-157 10mg + TB-500 10mg + GHK-Cu 100mg GLOW Bundle | For Research Use Only

(This section covers general laboratory handling and solution-preparation math, it is not guidance for human administration.)

Handling and Storage

  • Store lyophilized (unreconstituted) peptide at -20°C for long-term stability.
  • Once reconstituted, refrigerate (not freeze) and avoid repeated freeze-thaw cycles, which degrade peptide structure.
  • Always check the CoA for the specific batch, and verify purity and any contaminant testing (including heavy metals) before use in any research application.
  • Use sterile technique when reconstituting to avoid microbial contamination of the vial.

What the Research Does and Doesn’t Show

It’s worth being direct about the state of the evidence: BPC-157 and TB-500 research is overwhelmingly preclinical (animal models, cell cultures) — a 2025 systematic review covering 36 studies found only one small human study on BPC-157 (12 patients, chronic knee pain) and no FDA approval or clinical safety data, and GHK-Cu has a mix of preclinical and some topical/dermatological human study data. No one has run dedicated published trials on the three-peptide combination itself. Suppliers and researchers extrapolate claims about the blend’s effects from single-compound studies rather than demonstrate them for the combination itself. Anyone evaluating this space should treat blend-specific benefit claims with real skepticism until combination-specific research exists.

Glow peptide blend FAQ

What ratio does GLOW peptide blend usually come in? Most commercial and research suppliers use a 5:1:1 ratio (GHK-Cu : BPC-157 : TB-500) and typically package it as 50mg/10mg/10mg per vial.

How do you reconstitute GLOW peptide blend? Researchers typically use bacteriostatic water and aim for a target concentration around 23.3 mg/mL — always calculate this per your specific vial’s total mg content.

Is GLOW peptide blend the same as buying BPC-157, TB-500, and GHK-Cu separately? Chemically, yes — it’s the same three peptides. The difference is convenience (one vial, one reconstitution, fixed ratio) versus flexibility (you set the ratio yourself). Peptide Bro’s GLOW Bundle ships BPC-157, TB-500, and GHK-Cu as three separate vials for exactly this reason.

Is GLOW peptide legal in Canada? Canadian suppliers sell research peptides including BPC-157, TB-500, and GHK-Cu under a research-use classification. Health Canada has not approved them for human consumption, drug sale, or therapeutic use.

Looking for more peptide research?

Browse all research guides →

Similar Posts

  • What is the KLOW Peptide Blend?

    What is the KLOW Peptide Blend? To answer what is the KLOW peptide blend, researchers must look at the recent shift toward multi-pathway laboratory models. KLOW is a specialized four-compound research blend combining GHK-Cu, BPC-157, TB-500, and KPV into a single lyophilized vial. Designed for complex in-vitro evaluations, it allows investigators to simultaneously study extracellular…

  • What Is Selank?

    What Is Selank? Selank is a synthetic heptapeptide studied in neurological and stress-response research models. It is based on tuftsin, with structural changes that improve stability for laboratory use. The research focuses on regulatory peptide activity in the central nervous system. In practical terms, researchers use Selank when they need a short, defined sequence related…

  • What Is BPC-157?

    What Is BPC-157? BPC-157 is a synthetic pentadecapeptide studied in laboratory research related to tissue signaling, gastrointestinal mucosal pathways, and angiogenic models. It is a 15-amino-acid sequence derived from a protective portion of body protection compound described in human gastric juice research literature. Researchers use this peptide when they need a short, defined peptide tool…

  • What Is MOTS-c?

    What Is MOTS-c? This peptide is a mitochondrial-derived peptide studied in metabolic regulation and cellular energy research. Unlike most research peptides designed as synthetic analogues of nuclear-encoded signals, MOTS-c comes from mitochondrial DNA itself. That origin is the main reason the work has drawn steady attention. It gives researchers a defined 16-amino-acid sequence for studying…

  • what-is-tirzepatide

    what is tirzepatide Tirzepatide (often shortened to tirz) is a synthetic 39-amino-acid peptide that activates two incretin receptors: GIP and GLP-1. In the literature it is also called LY3298176. It is not a triple agonist. Retatrutide, which adds the glucagon receptor, is a different compound. Peptide Bros lists tirzepatide as a research material. Lot PB-TIRZ-0904,…

  • What Is Melanotan 1?

    What Is Melanotan 1? Melanotan 1 is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH). In laboratory research, it is used to study melanocortin receptor activity, especially pathways tied to MC1R signaling and pigmentation-related cellular responses. You will also see this compound under two other names: afamelanotide and [Nle⁴, D-Phe⁷]-α-MSH. Those names refer to the same…